Collaboration Details

Print  Close


Title of Collaborative Activity:

Regenerative Medicine Project

Description of Collaborative Activity:

The Regenerative Medicine Innovation Project (RMIP) was established by the 21st Century Cures Act to accelerate progress in the field by supporting clinical research on adult stem cells, while promoting scientific rigor and protecting patient safety. This initiative is a trans-NIH effort, in coordination with the Food and Drug Administration (FDA).

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:

2017

NIH Participating Institutes/Centers/Office of the Director:

NIA

HHS Agency Collaborators on this Activity:

FDA